• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Anika Therapeutics Inc. (ANIK)

    -NasdaqGS
    47.38 Up 0.85(1.83%) May 27, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 22,283   30,894   23,681   22,904  
    Cost of Revenue5,425  6,290  5,176  5,274  
    Gross Profit 16,858   24,604   18,506   17,629  
    Operating Expenses
    Research Development2,159  3,015  2,062  1,812  
    Selling General and Administrative3,990  4,523  3,309  3,388  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 10,709   17,066   13,135   12,429  
    Income from Continuing Operations
    Total Other Income/Expenses Net72   -  34  24  
    Earnings Before Interest And Taxes10,781  17,104  13,169  12,453  
    Interest Expense -   -   -   -  
    Income Before Tax10,781  17,104  13,169  12,453  
    Income Tax Expense3,886  6,061  4,789  4,634  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops6,895  11,043  8,380  7,819  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 6,895   11,043   8,380   7,819  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 6,895   11,043   8,380   7,819  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.